About MetaLens AI

MetaLens AI was created with a singular mission: to make evidence-based medical research accessible to everyone. We believe that the power of scientific literature should not be locked behind paywalls, complex search interfaces, or hours of manual reading. By combining the vast repository of PubMed — the world's largest biomedical database containing over 40 million citations — with cutting-edge generative AI, MetaLens AI delivers instant, structured meta-analysis summaries that distill the collective findings of hundreds of research papers into clear, actionable insights.

Our goal is to bridge the gap between raw scientific data and practical understanding. Whether you are a medical student preparing for exams, a pharmacist evaluating drug interactions, a clinical researcher surveying the landscape of a new therapeutic area, or a curious individual seeking reliable health information, MetaLens AI empowers you to make informed decisions grounded in the best available evidence.

Every day, thousands of new biomedical articles are published across the globe. PubMed alone indexes more than 1.5 million new citations each year, spanning topics from oncology and cardiology to pharmacology and public health. For healthcare professionals and researchers, staying up to date with the latest evidence is not just a professional requirement — it is an ethical obligation that directly impacts patient outcomes.

Yet the traditional process of conducting a literature review is painstakingly slow. A conventional systematic review can take anywhere from six months to over a year to complete. Even a focused search on PubMed requires researchers to manually sift through dozens or hundreds of abstracts, evaluate study quality, extract key findings, and synthesize results — a process that typically consumes 20 to 40 hours of skilled labor for a single topic.

MetaLens AI compresses this workflow from hours to seconds. By automating the search, retrieval, and synthesis steps, we free researchers to focus on what matters most: interpreting results, designing studies, and caring for patients.

MetaLens AI operates through a sophisticated multi-stage pipeline that combines proven biomedical infrastructure with state-of-the-art artificial intelligence:

• PubMed E-Utilities API:When you enter a medical keyword or research question, MetaLens AI queries the National Library of Medicine's PubMed database in real time using the official E-Utilities API. This ensures that every search draws from the same authoritative source used by researchers and clinicians worldwide.
• Smart Abstract Retrieval: Our system retrieves the most relevant abstracts based on your query, applying relevance ranking and recency filters to surface the most pertinent studies. Depending on your subscription tier, we analyze between 10 and 80 abstracts per query.
• Google Gemini AI Synthesis:The retrieved abstracts are processed by Google's Gemini large language model, which has been specifically prompted to perform structured meta-analysis. The AI identifies common themes, compares study outcomes, notes areas of consensus and disagreement, and generates a coherent summary that mirrors the structure of a professional systematic review.
• Structured Output: Results are presented in a clear, organized format including an executive summary, key findings, methodology overview, areas of agreement, conflicting evidence, clinical implications, and suggestions for future research.

We take the accuracy and transparency of our analyses seriously. Every MetaLens AI report includes full citations with PubMed IDs (PMIDs) so you can verify any claim against the original source material. We do not fabricate references or generate fictional studies — every citation in our reports links directly to a real, published paper in the PubMed database.

That said, we are transparent about the limitations of AI-generated analysis. While MetaLens AI provides valuable research summaries, it is not a substitute for a formal systematic review conducted by domain experts following PRISMA guidelines. AI can occasionally misinterpret nuanced statistical findings or overlook methodological limitations that a trained reviewer would catch. We encourage all users to treat MetaLens AI results as a starting point for further investigation, not as definitive medical guidance.

MetaLens AI is designed for a broad audience of healthcare professionals, researchers, and lifelong learners:

• Medical Students: Quickly survey the literature on clinical topics, prepare for case presentations, and understand the evidence base behind treatment guidelines.
• Pharmacists and Pharmacy Students: Evaluate drug efficacy, compare therapeutic alternatives, and stay current with pharmacological research.
• Clinical Researchers: Rapidly assess the existing body of evidence before designing new studies, identify knowledge gaps, and generate hypotheses.
• Physicians and Clinicians: Access concise evidence summaries at the point of care to support clinical decision-making and patient consultations.
• Public Health Professionals: Monitor emerging evidence on population health topics, vaccine effectiveness, and epidemiological trends.
• Health-Curious Individuals: Gain a deeper understanding of medical topics backed by peer-reviewed research rather than anecdotal sources.

MetaLens AI is developed and maintained by SPINAI, an independent software studio focused on building intelligent tools that solve real-world problems in healthcare and scientific research. We believe that artificial intelligence should serve as an equalizer — giving individuals and small teams access to capabilities that were previously available only to well-funded research institutions.

Our development philosophy centers on three principles: accessibility (keeping our core features free), transparency (always showing our sources), and continuous improvement (regularly updating our AI models and search capabilities based on user feedback).

We are firm believers in open access to scientific knowledge. MetaLens AI's Free tier provides meaningful analytical capability at no cost — not a crippled trial, but a genuinely useful tool. Our paid tiers (Pro and Ultra) offer expanded capacity for power users who need to analyze more papers per query and run more analyses per month, but the core experience remains available to everyone.

MetaLens AI supports eight languages to serve the global research community. We are continuously expanding our language support and feature set to reach more researchers in more countries.